New JTH Research on Bleeding Risk in Pregnant Women Treated for Acute Venous Thromboembolism
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn:
“The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
This multinational study assessed bleeding risk in pregnant women treated with low-molecular-weight heparins (LMWH) for acute VTE. It found no significant difference in bleeding risk between LMWH types or dosing schedules, highlighting the need for further research to optimize anticoagulation care in pregnancy.”
Title: The risk of bleeding in pregnant women with acute venous thromboembolism treated with anticoagulants: an international multidatabase cohort study
Authors: Camille Simard, Isabelle Malhamé, Christopher Filliter, Annika Vivirito, Kristian B. Filion, Haim Abenhaim, Dirk Enders, Antonios Douros, Vicky Tagalakis
Read the full article here.
Find similar posts on Hemostasis Today.
-
Mar 18, 2026, 16:34Richard Buka: Exploring the COBRRA Trial in the Latest Episode of Don’t Just Read the Abstract
-
Mar 18, 2026, 16:22Heghine Khachatryan: Navigating the New Era of Hemophilia Gene Therapy
-
Mar 18, 2026, 16:21Georges Chahoud: Top Take-Home Messages from the AHA/ACC/Multisociety Acute PE Guideline
-
Mar 18, 2026, 16:19Cedric Hermans: Unleashing the Potential of Physical Activity in Hemophilia A Patients
-
Mar 18, 2026, 16:17Asif Mushtaq: Managing Cardiac Surgery with Cardiopulmonary Bypass in Hemophilia
-
Mar 18, 2026, 16:15Amir Kraitzer: Engineering Hemocompatible Surfaces to Overcome Thrombosis in Medical Devices
-
Mar 18, 2026, 16:11Hemant Sharma: Advancing Neonatal Care with New Strategies to Prevent IVH
-
Mar 18, 2026, 16:09Yves Bikorimana: How a Simple Temperature Change Can Trigger Antibody-Mediated Destruction of RBCs
-
Mar 18, 2026, 16:07Scott Isaacs: Optimizing Brain Vitality and Slowing Neurodegeneration Through Daily Habits